PharMerica's 2026-2027 Adult Immunization Guide

Managing an adult immunization program means keeping up with changing vaccine recommendations, documentation requirements, reimbursement policies, and compliance expectations. Our updated Adult Immunization Guide brings these resources together in one place, helping teams spend less time searching for information and more time managing care.

Aligning Pharmacy Partnership with the Reality of Senior Living

As resident acuity rises and staffing pressure continues, senior living operators need pharmacy partners that provide more than just medication delivery. In this feature appearing in the latest issue of Provider, PharMerica clinical and senior living leaders explore how proactive clinical oversight, cycle fill workflows, and staff education platforms can ease caregiver burdens and streamline daily operations.

Navigating Safely Through Fall Risk Calculation

Physical hazards and gait instability are clear fall risks, but hidden factors like anticholinergic burden can quietly elevate resident vulnerability. Our newly updated guide connects clinical assessments with pharmacy insights to deliver a complete picture of resident fall risk. Learn how combining tools like the Morse Fall Scale and STEADI-Rx medication reviews empowers your team to pinpoint modifiable risks and prevent falls.  

CDC QuickStats: Death Rates from Unintentional Falls Among Adults Aged ≥65 Years, by Sex and Age Group — United States, 2024 

Unintentional falls remain a leading cause of injury-related mortality in older populations, with risk escalating sharply for adults over age 85. For clinicians, mitigating these risks requires proactive interventions, including routine mobility assessments and thorough medication reviews to limit fall-inducing side effects. This CDC report offers essential benchmarking data to support your facility’s clinical quality and fall-prevention initiatives.

Compliance Cue: 2026 Medicare GLP-1 Bridge Program

On July 1, 2026, CMS launched the Medicare GLP-1 Bridge Program, providing eligible Medicare Part D beneficiaries access to select glucagon-like peptide-1 (GLP-1) receptor agonists FDA-approved for the indication of weight loss. GLP-1 medications prescribed for other indications, such as for the treatment of diabetes, will not be covered under the pilot program. 

4-part webinar series with NADONA

The Successful DON, Part 4: Relationships Matter

November 17, 2026

1:00 pm ET

This webinar will explore the many relationships that need to be established and nurtured by DONs. Each relationship adds to the culture of the facility and is an indicator of its success, as well as the health and well-being of its residents. Join Cindy Fronning and Nancy Tuders from NADONA as they team up with PharMerica's Caroline Garvey to discuss these crucial relationships and their impacts.